Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMAA) reported Total Current Liabilities of $376172.0 for Q4 2025, down 52.72% on a YoY basis from $795669.0 in Q4 2024, and down 17.62% quarter-over-quarter from $456611.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition has reported Total Current Liabilities for 2 years, with the latest figure at $376172.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities fell 52.72% year-over-year to $376172.0; the trailing twelve-month figure through Dec 2025 stood at $376172.0 (down 52.72% YoY), and the FY2025 full-year result was $376172.0, down 52.72% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $376172.0, down from $456611.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $795669.0 in Q4 2024, with the low at $301441.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 264,756.00 |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 885,401.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 155,870.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 634,612.00 |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 945,150.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 131,332.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 239,898.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 3.39 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 125,224.00 |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | 376,172.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 376,172.00 |
| Sep 30, 2025 | 456,611.00 |
| Jun 30, 2025 | 301,441.00 |
| Mar 31, 2025 | 347,369.00 |
| Dec 31, 2024 | 795,669.00 |